mikehavRx.com Index Updates is a premium service that provides investors with time-saving information and updates on global baskets of stocks (over 1,000 stocks) that are organized and managed within the 18 HavRx Stock Indexes. The service is provided in the form of 22 PDFs at the subscriber home page which can be accessed upon successful log-in. This is a no-hype, information-based service focused on the healthcare sector and medical innovation that is designed for self-directed investors and traders.
<font> An additional Google Calendar has been added to the subscriber home page to track upcoming quarterly conference calls, presentations, and related events for companies being tracked in the 17 passively managed HavRx stock indexes. This adds to the recently added Google Calendar for the Regulatory Catalyst Index active components and watch list stocks (over 300 stocks), which complements the five daily update reports for binary event tracking data. </font>
<font> The Regulatory Catalyst Index reports are updated daily on regular business days between 6-8pm (ET) and the five reports are sorted by company name, stock ticker, catalyst date, stock price, and the date of most recent update for each entry. Regulatory Catalyst Index update statistics (as of 4/23/10) are summarized below. </font>
<font> - 503 total entries to track select pending binary event data (FDA decisions, clinical trials) </font>
<font> - 308 companies tracked, including 115 active index components </font>
<font> - 226 companies under $10 per share, 169 companies under $5 per share </font>
<font> Below is the updated performance tracking statistics and data for the HavRx stock indexes, representing subsector indexes and new exchange-traded fund ideas as follow-on products to popular sector-based ETFs such as the Healthcare SPDR (XLV), iShares Dow Jones Transports (IYT), and iShares NASDAQ Biotech (IBB). </font>
<font> HavRx Index Stats as of 23-April 2010, Tracking Start Date, # Stocks, Last Price, % Chg </font>
<font> Healthcare Stock Indexes (13)
Regulatory Catalyst 6/21/09 115 $2,126.81 112.7%
Diabetes Care 11/19/09 46 $1,193.54 19.4%
Cosmetic / Restorative Medicine 6/24/09 78 $1,419.82 42.0%
Life Science Leaders 12/15/09 25 $1,000.41 0.0%
Natural Health 12/15/09 52 $1,094.89 9.5%
Immune Therapy / Vaccines 12/15/09 52 $1,298.06 29.8%
Emerging Cancer Dx / Tx 6/21/09 85 $2,125.45 112.5%
Global Generic Drugs 6/24/09 75 $1,685.82 68.6%
Global Health IT 6/24/09 55 $1,403.10 40.3%
Global Hospitals 6/28/09 51 $1,443.44 44.3%
Stem Cells 6/22/09 48 $1,340.88 34.1%
Health Benefit Providers 6/21/09 54 $1,549.40 54.9%
Global Crop Science 12/17/09 48 $1,048.23 4.8% </font>
<font> Non-Health Stock Indexes (5)
Global Clean-Tech 6/21/09 58 $1,360.28 36.0%
Global Railroad Industry 6/24/09 46 $1,580.24 58.0%
Global Tobacco Industry 6/21/09 21 $1,560.12 56.0%
Global Trucking / Logistics 6/24/09 47 $1,382.25 38.2%
Global Air Transport 6/24/09 48 $2,137.33 113.7% </font>
<font> www.mikehavRx.com </font> <font> is your prescription for stock index investing updates focused on the healthcare sector, medical innovation, and pending binary events such as FDA decisions and clinical trials. The actively managed HavRx Regulatory Catalyst Index update report is currently tracking 502 entries and 308 companies (including over 150 stocks trading under $5 per share). Promo codes (50% discount) are also available for college students, investment clubs, and subscribers to my previous FDA Calendar or similar services. </font>
<font> Disclosure: No positions </font>
$90.79 (04/23/10)
